Advanced Health Intelligence (MYZQF) 6-K AHI Signs Letter of Intent with UAE-based E-Script medicine management company Pharmak Direct

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 OF

THE SECURITIES EXCHANGE ACT OF 1934

For the month of June 2023

Commission File Number: 001-41089

Advanced Health Intelligence Ltd

(Translation of registrant’s name into English)

71-73 South Perth Esplanade, Unit 5

South Perth, WA 6151

Australia

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

INFORMATION CONTAINED IN THIS FORM 6-K REPORT

Attached as Exhibits 99.1 and 99.2 to this Report on Form 6-K are copies of the press releases of Advanced Health Intelligence Ltd, dated June 21, 2023: “AHI Signs Letter of Intent with UAE-based E-Script medicine management company Pharmak Direct”, and “AHI Announces Early Redemption of A$1.75 million of Convertible Notes”.

99.1	Press release dated June 21, 2023
99.2	Press release dated June 21, 2023

1

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	ADVANCED HEALTH INTELLIGENCE LTD
Date: June 21, 2023	By:	/s/ Scott Montgomery
		Name:	Scott Montgomery
		Title:	Chief Executive Officer

2